Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma. - Shi X; Yan L; Shang J; Kang L; Yan Z; Jin S; Zhu M; Chang H; Gong F; Zhou J; Chen G; Pan J; et al. (American journal of hematology, 2022)